ACN monthly performance report
Monthly ACN research: returns, drawdown, relative strength, seasonality, and key stats.
ACN monthly report
—
Key takeaways
- Accenture (ACN) closed September 2026 at $183.90, down 3.09% for the month and −24.68% over the trailing 12 months.
- Year-to-date, ACN is −31.46%, underperforming the S&P 500 which has returned +12.08% YTD.
- The stock is trading −9.33% versus its 200-day moving average ($202.81), a cautious technical signal.
- Over the past three years, ACN has underperformed the S&P 500 by −114.00%, with a relative strength index reading of 33.1.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Accenture ended September 2026 at $183.90, posting a monthly return of −3.09%. The S&P 500 returned −0.36% over the same window, leaving relative performance at −2.73%.
The current quarter stands at +47.78% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −9.33% versus the 200-day moving average ($202.81).
Year-to-date, ACN is −31.46% against SPY +12.08%, a gap of −43.54%. The stock is currently −36.82% below its 52-week high, with maximum 3-year drawdown at −68.75%.
| Period | ACN | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +3.37% | +0.85% | +2.51% |
| 1 Week | −2.01% | −0.11% | −1.90% |
| 1 Month | −3.09% | −0.36% | −2.73% |
| 3 Months | +6.01% | +5.36% | +0.66% |
| 6 Months | −14.47% | +12.68% | −27.15% |
| YTD | −31.46% | +12.08% | −43.54% |
| 12 Months | −24.68% | +16.22% | −40.90% |
| 3 Years | −43.57% | +70.43% | −114.00% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +33.33% |
| #2 | Aug 2026 | +14.37% |
| #3 | Nov 2023 | +12.13% |
| #4 | Jan 2025 | +9.43% |
| #5 | Jul 2024 | +8.97% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jun 2026 | −33.48% |
| #2 | Feb 2026 | −20.83% |
| #3 | Apr 2024 | −13.18% |
| #4 | Jul 2025 | −10.64% |
| #5 | Mar 2025 | −10.46% |
| Quarter | Return |
|---|---|
| Q2 2025 | −4.21% |
| Q3 2025 | −17.49% |
| Q4 2025 | +8.80% |
| Q1 2026 | −26.09% |
| Q2 2026 | −37.24% |
| Q3 2026 (QTD) | +47.78% |
| Year | Return |
|---|---|
| 2023 | +31.51% |
| 2024 | +0.25% |
| 2025 | −23.73% |
| 2026 | −31.46% |
| Metric | Value |
|---|---|
| 52-Week High | $291.09 (2026-01-14) |
| 52-Week Low | $118.15 (2026-06-22) |
| Current Price | $183.90 |
| 200-Day Moving Average | $202.81 |
| Price vs 200DMA | −9.33% |
| 3-Year Maximum Drawdown | −68.75% (2026-06-30) |
| Current Drawdown from 52W High | −36.82% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 33.1 |
| 3-Year Excess Return vs S&P 500 | −114.00% |
| RS Peak | 105 (Jan 2024) |
| RS Trough | 22.9 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was ACN's return for this report period?
ACN returned −3.09% in the latest monthly window ending 2026-09-11.
Has ACN outperformed SPY year to date?
YTD ACN: −31.46% vs SPY: +12.08%.
What is ACN's 12-month return?
−24.68% over the trailing 12 months.
Is ACN above or below its 200-day moving average?
Price is −9.33% versus 200DMA ($202.81).
What is the maximum drawdown in the 3-year window?
−68.75% on 2026-06-30.